Cindy Reiss-Clark - Aug 22, 2023 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
Chief Commercial Officer
Signature
/s/ Cynthia Reiss-Clark
Stock symbol
WST
Transactions as of
Aug 22, 2023
Transactions value $
-$1,820,279
Form type
4
Date filed
8/24/2023, 07:24 PM
Previous filing
Feb 23, 2023
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $193K +1.11K +25.74% $173.22 5.43K Aug 22, 2023 Direct
transaction WST Common Stock Options Exercise $436K +1.59K +29.23% $274.29 7.02K Aug 22, 2023 Direct
transaction WST Common Stock Options Exercise $287K +777 +11.07% $369.13 7.8K Aug 22, 2023 Direct
transaction WST Common Stock Sale -$1.37M -3.48K -44.59% $393.34 4.32K Aug 22, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to buy) Options Exercise -$306K -777 -25% $393.34 2.33K Aug 22, 2023 Common Stock 777 $369.13 Direct F1
transaction WST Stock Options (Right to buy) Options Exercise -$625K -1.59K -50% $393.34 1.59K Aug 22, 2023 Common Stock 1.59K $274.29 Direct F2
transaction WST Stock Options (Right to buy) Options Exercise -$437K -1.11K -38.77% $393.34 1.76K Aug 22, 2023 Common Stock 1.11K $173.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in four equal annual installments beginning on February 22, 2023.
F2 This award vests in four equal annual installments beginning on February 23, 2022.
F3 This award vests in four equal annual installments beginning on February 18, 2021.